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Off-pump coronary artery bypass surgery by avoiding cardioplegic arrest seems to reduce the risk of ischemic
myocardial injury. However, even short-term regional ischemic periods, hemodynamic instability and arrhythmias
associated with the procedure can be responsible for myocardial damage. Conditioning, a potential cardio-protective
tool during on-pump cardiac surgery, has hardly been investigated in the context of off-pump surgery. There are
virtually no large trials on remote ischemic preconditioning and the majority of reports have focused on central
ischemic conditioning. Similarly, volatile anesthetic agents with conditioning effect like ischemic preconditioning have
been shown to reduce cardiac injury during on-pump procedures but have not been validated in the off-pump
scenario. Here, we review the available evidence on myocardial conditioning, either with ischemia/reperfusion or
volatile anesthetic agents in patients undergoing off-pump coronary artery surgery.
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Conditioning is an umbrella definition that consists of
pre-conditioning, per-conditioning and post-conditioning
[1]. Conditioning can be elicited remotely (e.g. at the level
of a limb) [2] or centrally (e.g. at the level of the heart) [3].
Stimulus normally consists of an ischemic period followed
by reperfusion [4], but other triggers like pain-stimulus
[5], hyperbaric oxygen [6] and most importantly methods
such as volatile anesthetics [7] have been advocated as be-
ing equally effective. Conditioning has been experimented
in cardiac surgery mainly in the form of remote ischemic
preconditioning (RIPC) and the majority of the largest
trials have been in on-pump CABG patients (ONCAB) [8]
or during valve surgery [9]. RIPC seems to lowers tropo-
nin release in patients undergoing ONCAB (‘proof of con-
cept’), but still unclear is if this leads to any better clinical
outcome. RIP Heart-Study will recruit over 2000 on-pump
patients and will include as primary outcomes all-cause
mortality, non-fatal MI, any new stroke and/or acute renal
failure [10] and the ERICCA [11] trial will establish if
there would be better clinical outcome in on-pump high-* Correspondence: m.moscarelli@imperial.ac.uk
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unless otherwise stated.risk patients. However, it is still an open question whether
conditioning has potential benefits in patients undergoing
OPCAB in terms of lowering troponin release and im-
proving clinical outcomes. Ischemia during OPCAB can
happen in 10% of cases [12] with ST segment elevation in
up to 40% of patients [13]. Although the use of intra-
coronary shunts can reduce the ischemic time, even short-
term regional ischemic periods or heart manipulations can
result in myocardial injury [14], and subsequent arrhyth-
mias and/or hemodynamic instability which can lead even
to conversion to ONCAB [15].
Several reports on the use of volatile anesthetics
cardio-protective agents in ONCAB surgery have sug-
gested a similar ischemic preconditioning effect. How-
ever, only small trials have investigated the effect of
anaesthetic preconditioning in OPCAB. The use of alter-
native methods such as adenosine, hyperbaric oxygen or
temperature in OPCAB is also yet to be validated. Opti-
mizing protection of the heart from ischemia/reperfusion
injury (I/R) during OPCAB is, therefore, a worthwhile
goal.Ischemic conditioning in OPCAB
Although there are evidences supporting the benefits of is-
chemic preconditioning (IP) in terms of cardio-protection,ral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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with just few studies published so far.
Malkowsky et al. [13] induced IP with 5 minutes of
local coronary artery occlusion and 5 minutes of reper-
fusion in a series of 17 single vessel OPCAB patients.
Left anterior descending artery (LAD) occlusion/reperfu-
sion increased left ventricle wall motion score (LVWMS)
and pulmonary pressure (PA). However, subsequent is-
chemia during the construction of the anastomosis did
not alter the regional LV systolic function. van Aarnhem
et al. [12] retrospectively reviewed a cohort of 200
OPCAB patients in whom ischemic preconditioning was
used before anastomosis by occluding the vessel for 5 mi-
nutes and then allowing 5 minutes of reperfusion. They
reported a 10% incidence of-intra operative ischemia
(defined as 1 mm ST segment elevation) but no peri-
operative myocardial injury. Intra–coronary shunts were
used in case of critical ischemia and no conversion to
ONCAB was observed. Laurikka et al. [14] showed that
IP, induced with two cycles of 2 minutes left anterior
descending artery occlusion (LAD) followed by 3 minutes
of reperfusion before the first coronary artery anasto-
mosis, decreased the immediate myocardial enzyme
release, reduced the post-operative increase in HR, and
enhanced the recovery of volume index after surgery.
Doy et al. demonstrated that a single cycle of 5 minutes
of central I/R attenuated ischemia-induced electro-
physiological changes in patients undergoing MIDCAB
[23]. Wu et al. [22] reported that IP, induced by to cycles
of 2 minutes occlusion of LAD followed by reperfusion,
led to a positive suppression of HR and reduced the inci-
dence of supra-ventricular and ventricular arrhythmias,
although the incidence of post-operative atrial fibrilla-
tion (AF) remained similar between preconditioned and
non-preconditioned groups. Drengen et al. [21] com-
pared prospectively a cohort of patients preconditioned
with a single cycle of 5 minutes of LAD occlusion
followed by 5 minutes of reperfusion and a cohort precon-
ditioned with 1.6% enflurane with a non-preconditioned
group. They reported a significant reduction of metabolic
deficit in both the IP and volatile groups compared to the
non-preconditioned group [21]. Hong et al. [19] carried
out a prospective controlled randomized trial on RIPC in
patients undergoing OPCAB. Remote ischemic precondi-
tioning was elicited with 4 cycles of 5 min upper limb
ischemia and 5 min of reperfusion after anesthesia. Tropo-
nin release was lower in the RIPC group but did not reach
statistical significance (p = 0.172) [19]. Succi et al. [20]
reported that IP, induced only by 1 minutes of LAD occlu-
sion followed by 2 minutes of reperfusion before anasto-
mosis prevented decrease in left ventricular contractility
Hong et al. [18] used both RIPC and postconditioning
(PostC) in a cohort of 35 OPCAB patients. Ischemic re-
mote preconditioning and PostC were elicited with 4 cyclesof 5 minutes of ischemia and 5 minutes of reperfusion of
the lower limb before and after anastomosis. They re-
ported a significant decrease in post-operative myocardial
enzymes. Forouzinna et al. [17] prospectively compared
patients preconditioned either with adenosine or with 2 cy-
cles of 2 minutes of LAD occlusion followed by reperfu-
sion with a non preconditioned control group. They
reported no differences in terms of post-operative EF and
enzyme release but the incidence of post-operative AF was
higher in the IP group although it did not reach statistical
significance. A recent pilot study by Jung et al. focusing on
neurological outcome did not show any benefits of RIPC
in patients undergoing OPCAB in terms of cognitive
outcomes [16].
Volatile anesthetic agents conditioning in OPCAB
Several reports investigating the potential use of volatile
anesthetics as preconditioning agents in OPCAB (Table 2)
have reported rather different results. Sevoflurane was
found to reduce troponin release in three trials [25-27],
although Orriach et al. used sevoflurane as well as post-
conditioning agent, extending its administration during
the first post-operative hours [25]. No differences in
troponin release were reported by other authors when
sevoflurane was compared to desflurane and propofol
[28], to propofol in a remifentanil-based anesthesia regime
[29,30] and to isoflurane alone [31,32]. Sevoflurane was
also showed to have several other benefits: better antioxi-
dative properties than propofol [33], reduced incidence of
arrhythmias compared to desflurane [34], better preserva-
tion of cardiac function compared to control and to pro-
pofol [35,36] and to reduced NBP release and plasma
protein A release when compared to propofol [37]. Isoflur-
ane was reported to reduce troponin release when com-
pared to propofol [38] but no differences were found
when compared to sevoflurane [31,32]. Other authors on
the contrary did not find differences in terms of troponin
release when it was compared to a propofol group of
patients [39]. Desflurane was reported to improve LSWI
when compared to a propofol anesthetic regime, although
no differences in troponin release were observed [40], and
moreover was found to be less effective in reducing inci-
dence of arrhythmias than sevoflurane [34]. Guarracino
et al. observed a significant reduction in troponin release
in a cohort of 57 patients anesthetized with desflurane
[41]. Finally, remifentanil was found to have a precondi-
tioning effect by lowering troponin release [42], however
no differences were reported when was associated with
sevoflurane and compared to propofol [30].
Alternative way to standard conditioning in OPCAB
There have been few reports on the use of adenosine as
preconditioning agent in OPCAB. Forouzinna et al. [17]
reported no differences between preconditioned and non
Table 1 Studies including ischemic conditioning
Author, date, journal and
country study type
Patient group Type of conditioning Outcomes Key results Comments
Joung et al. (2013) Korean
J Anestesiol, Korea [16]
Prospective controlled
randomized trial
Seventy OPCAB RIPC 4 cycles of 5 min ischemia
and 5 min of reperfusion before
coronary artery anastomoses
Six cognitive
function test day 1
after surgery
Post-operative cognitive dysfunction
was 28.6% (10 pts) and 31.4% (11 p
in RIPC and Control group respectiv
RIPC did not reduce incidence of
post-op cognitive dysfunction
after OPCABG during the immediate
post-op period
35 RIPC
35 Control
Forouzannia et al. (2013)
J The Univ Heart Ctr, Iran
[17] Prospective controlled
randomized trial
Sixty OPCAB Adenosine. Post-op EF IP and adenosine did not elicit
statistically significant EF preservatio
compared to the control group
No difference found in post-op EF
and enzymes release in between
groups. Incidence of arrhythmias
was higher in the IP group but
did not reach statistical significance
20 Adenosine IP induced with twice 2 min
LAD occlusion followed 3 min
reperfusion before the first
anastomosis
Arrhythmias
20 IP Troponin/CK-MB
20 Control
Hong et al. (2012) Circulation
Journal, Japan [18] Prospective
controlled randomized trial
Seventy OPCAB Lower limb 4 cycles of 5 min
ischemia and 5 min of
reperfusion before anastomoses
(RIPC) and after anastomoses
(RIPostC)
Troponin release RIPC + RIPostC significantly reduced
postoperative serum troponin I leve
RIPC + RIPostC decreased postoperative
myocardial enzyme elevation by
almost half postoperatively in patients
undergoing OPCAB
35 RIPC +
RIPpostC
35 Control
Hong et al. (2010)] Anaesth
Intensive Care, Korea [19]
Prospective randomized
controlled trial
130 OPCAB Upper limb 4 cycles of 5 min
ischemia and 5 min of
reperfusion after anesthesia
Troponin release Troponin release was lower in the R
group but was not statistically signi nt
RIPC did not reduce significantly
post-operative myocardial
enzyme release65 RIPC
65 Control
Succi et al. (2010) Arq Bras
Cardiol, Brasil [20] Prospective
controlled randomized trial
Forty OPCAB IP induced with twice 1 min
LAD occlusion followed 2 min
reperfusion before the
anastomosis
Intra-op EF
(measured pulsed
Doppler of the
descending
thoracic aorta)
Acceleration of the aortic blood flow
with no differences in between
groups; IP group maintained left
ventricular contractility during the
entire procedure while the control
group presented significant reducti
in left ventricular contractility
IP prevented the decrease in left
ventricular contractility during
off-pump myocardial
revascularization surgery
0 IP
20 Control
Drenger et al. (2008) Journal
of Cardiothoracic and Vascular
Anesthesia, Israel [21]
Prospective controlled
randomized trial
Twenty five
OPCAB
IP induced with single 5 min
LAD occlusion followed by
5 min reperfusion 1.6% ENF
started 15 min before LAD
occlusion
Myocardial
metabolism
Lactate production in the ENF grou
decreased significantly compared w
control and IP groups. Oxygen utiliz n
in the control was 44% higher than
other two groups. Early recovery of
anterior wall hypokinesis in both
study group
Application of methods such as IP
or volatile anesthesia appeared to
reduce the metabolic deficit
8 Control
9 IP
8 Enflurane
Wu et al. (2003) Journal of
Cardiothoracic and Vascular
Anesthesia, Finland [22]
Prospective controlled
randomized trial
Thirty two
OPCAB
IP induced with twice 2 min
LAD occlusion followed 3 min
reperfusion before the first
anastomosis
Incidence of
post-operative
arrhythmias
IP suppressed the HR elevation duri the
time of myocardial ischemia and re fusion
and significantly reduced the incide of VT
after surgery. Incidence of SVT durin to
24 hours after surgery was lower in IP
patients but incidence of SVES, VES d AF
were similar between the 2 groups
Arrhythmia was a common
phenomenon during and after
OPCAB procedure; IP protocol
significantly suppressed HR
elevation, episodes of SVT, and
incidence of VT after surgery but
incidence of post-op AF was similar
in between groups
16 IP
16 Control
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Table 1 Studies including ischemic conditioning (Continued)
Doi et al. (2003) Jpn J Thorac
Cardiovasc Surg, Japan [23]
Prospective observational study
Forty-five
OPCAB
(MIDCAB)
IP induced with 5 min vessel
occlusion followed 5 min
reperfusion before anastomosis
phiL/phiT, QT, JT
dispersions before,
during and after IP
and during and
after coronary
anastomosis
Anisotropy was exaggerated during the
5-minute coronary occlusion; during
anastomosis, conduction velocities were
decreased, but showed no further
deterioration; QT and JT dispersions
were improved by reperfusion
Anisotropy and dispersions were
minimized after IP, therefore IP
demonstrated antiarrhythmic
protective effects on the
human myocardium
Laurikka et al. (2003) Chest,
Finland [14] Prospective
controlled randomized trial
Thirty-two
OPCAB
IP induced with cycle of twice
2 min LAD occlusion followed
3 min reperfusion before the
first anastomosis
Myocardial
performance
IP group had complete recovery of mean
after the operation; in the control
subjects, mean SVI showed a
significant reduction postoperatively
IP tended to decrease the immediate
myocardial enzyme release, prohibited
the postoperative increase in HR, and
enhanced the recovery of SVI16 IP
16 Control
Matsumoto et al. (2001)
Kyobu Geka, Japan [24]
Retrospective observational
study
Forty-three
OPCAB
IP induced with twice 5 min
vessel occlusion followed 5 min
reperfusion before anastomosis
Allopurinol preoperatively and
nicorandil intraoperatively;
Myocardial tissue
oxygen saturation
Troponin level was statistically significant
lower in the IP groupOn day 1 post op,
the increase in the mean HR was also
significantly lower in the IP group
Significant amelioration of post-ischemic
recovery in the IP + pharmacological
preconditioning
Concomitant use of IP and KATP opener,
oxidative radical scavenger both
ameliorated cardiac dysfunction during
ischemia in anastomotic occlusion of
the coronary artery and improved the
post-ischemic functional recovery
12 IP
29 IP+
pharmacological
Post-ischemic
functional recovery
van Aarnhem et al. (1999)
Eur J Cardiothorac Surg,
The Netherlands [12]
Retrospective observational
study
Two-hundred
OPCAB
IP induced with 5 min of local
coronary artery occlusion and
5 min of reperfusion before
anastomosis
Ischemia during
temporary
coronary artery
occlusions
Ischemia (defined as defined
as > 1 mm S-T segment) occurred
during 35 (10%) temporary coronary
artery occlusions
Temporary segmental occlusion was safe
before anastomosis in OPCAB; shunts
were used in critical ischemiaIschemic
dysfunction was precipitated by the
5-min LAD occlusion, as shown by the
increase in LVWMS and PA pressure.
However, a 5-min coronary occlusion
and the resulting ischemia did not alter
regional LV systolic function during
subsequent ischemia
There were no perioperative MI/no
conversion to ONCAB LVWMS decreased
significantly after first cycle but improved
after IP No significant differences in
pulmonary artery pressures were
after IP and during anastomosis
Malkowski (1998) J Am Coll
Cardiol (USA) [13] Prospective
observational study
Seventeen
OPCAB
(MIDCAB)
IP induced with 5 min of
local coronary artery
occlusion and 5 min
of reperfusion
LVWMS
PA systolic and
diastolic pressure
AF: Atrial fibrillation; IP: Ischemic preconditioning; I/R: Ischemia reperfusion; LAD: Left anterior descending artery; LVWMS: Left ventricle wall motion score; MIDCAB: Minimally invasive direct coronary artery bypass
grafting; ONCAB: On-pump CABG; OPCAB: Off-pump CABG; phiL/phiT: Ratio of longitudinal to transverse conduction velocity PostC: Postconditioning; RIPC: Ischemic remote preconditioning; SVI: Stroke volume index;
SS: Sevoflurane.
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Table 2 Studies including anaesthetics agents
Mroziński et al. (2014)
Anaesthesiol Intensive Ther,
Poland [40] Prospective
randomized open-label trial
Sixty OPCAB 28
Propofol 32
Desflurane
DES PP Assessment of hemodynamic
function and myocardial
injury markers
DES group demonstrated improved
stability, expressed as LVSWI; no
differences in myocardial injury in
between groups
No difference reported between DES
and PP in major haemodynamic
parameters, myocardial injury markers
and the long-term outcome; DES might
accelerate LVSWI recovery
Orriach et al. (2013) J Crit Care,
Spain [25] Prospective
randomized trial
Sixty OPCAB SS and PP
(intra-op and
post op as
postconditioning)
BNP Troponin release Need
for inotropic drugs
SS group had reduced BNP, troponin
release and number of inotropic
drugs Compared to S-P and
P-P groups
SS administration in OR and CICU,
decreased troponin release compared
with SS intra-op, but both were a
better option to decrease troponin
level when compared to PP
20
Sevoflurane/
Sevoflurane (S-S)
20 Sevoflurane/
Propofol (S-P) 20
Propofol/Propofol
(P-P)
Wang et al. (2013)
Scand Cardiovasc J, China
[26] Prospective randomized
controlled trial
Forty-eight OPCAB SS BNP SS significantly decreased post-surgical
troponin levels No significant differences
in BNP level among groups
SS exerted significant myocardial
protective effect; BNP could not
predict myocardial protective
effect of SS in OPCAB
20 Sevoflurane Troponin release
20 Control
Suryaprakash et al. (2013)
Ann Card Anaesth, India [28]
Prospective randomized trial
One hundred
thirty
SS Troponin release Changes in troponin levels at all time
intervals were comparable in the
three groups
No difference found in myocardial
protection with SS or DES or PP
nine OPCAB DES
48 Sevoflurane PP
52 Desflurane
39 Propofol
Tempe et al. (2011)
J Cardiothorac Vasc Anesth,
India [38] Prospective
randomized trial
Forty-five OPCAB ISO Troponin release Troponin release in the PP group was
significantly higher than the ISO group at
6 and 24 hours after surgery
ISO provided protection against
myocardial damage by lowering
levels of troponin-TIsoflurane PP
Propofol
Ballester et al. (2011)
Eur J Anaesthesiol, Spain [33]
Prospective controlled
randomized trial
Thirty-eight
OPCAB
SS Markers of lipoperoxidation
(F2-isoprostanes) and
nitrosative stress
(nitrates/nitrites) measured
in coronary sinus blood
F2-isoprostanes concentrations were
significant lower in the SS group at all
different time point
SS showed better antioxidative
properties than PP
20 Sevoflurane PP
18 Propofol
Kim et al. (2011)
Anaesth Intensive Care, Korea
[29] Prospective randomized
controlled trial
Ninety-four
OPCAB
SS CK MB and troponin release No statistically differences in between
groups in terms of CK-MB and troponin
release at different end points
SS and PP had similar CK-MB
and troponin values
47 Sevoflurane PP
47 Propofol (both in a
remifentanil based
anesthesia)
Hammerling et al. (2010)
Ann Card Anaesth Canada [34]
Prospective double blinded trial
Forty OPCAB SS Incidence of arrhythmias Supraventricular tachycardia occurred only
in the DES-group, AF was significantly
more frequent in the DES group versus
SEVO-group
SS found to be more advantageous
than DES, as it was associated with
less AF or supraventricular
arrhythmias
20 Sevoflurane DES
20 Desflurane
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Table 2 Studies including anaesthetics agents (Continued)
Xu (2009) J South Med Univ,
China [42] Prospective
controlled randomized trial
Twenty four
OPCAB
REMI Troponin release Statistically significant reduction of
troponin level in the REMI group
Troponin levels of REMI preconditioning
group were markedly decreased after
the operation in comparison with
those of the control group12 Remifentanil
12 Control
Drenger et al. (2008) Journal of
Cardiothoracic and Vascular
Anesthesia, Israel [21] Prospective
controlled randomized trial
Twenty five
OPCAB
IP induced with
single 5 min LAD
occlusion followed
by 5 min reperfusion
1.6% ENF started
15 min before
LAD occlusion
Myocardial metabolism Lactate production in the ENF
group decreased significantly
compared with control and IP
groups. Oxygen utilization in the
control group was 44% higher than
the other two groups Early recovery of
anterior wall hypokinesis in both
study groups
Application of methods such as IP or
volatile anesthesia appeared to
reduce the metabolic deficit
8 Control
9 IP
8 Enflurane
Hemmerling (2008) European Journal
of Anaesthesiology, Canada [31]
Prospective randomised trial
Fourty OPCAB SS Troponin/CK-MB No differences in terms of enzymes
release, heart contractility and
haemodynamic values Extubation
time was significantly shorter with
SS compared to ISO
SS and ISO provided the same ischaemic
cardio-protective effects; SEVO allowed
a more rapid recovery from anaesthesia20 Sevoflurane ISO LVWM abnormalities time to
extubation/respiratory
functions haemodynamic
parameters
20 Isoflurane
Huseidzinović et al. (2007)
Croat Med J, Croatia [35]
Prospective randomised
controlled trial
32 OPCABG SS Acceleration of aortic blood
flow, CI, HR, mean arterial
pressure, and central venous
pressure at different time
points
SS group showed better CI values at
the beginning of ischemia and 15 minutes
after ischemia; in the PP group acceleration
decreased and remained lower 15 minutes
after sternal closure while was increased
in the SS group
Cardiac function was better preserved
in patients with SS than with PP
16 Sevoflurane
16 Control
Venkatesh et al. (2007)
Ann Card Anaesth, India [32]
Prospective randomized
Forty OPCAB SS Haemodynamic effects
amount of analgesia needed
postoperative recovery
No differences identified in terms of
haemodynamic parameters, depth of
anesthesia, and quantity of agent
needed; time of awakening and
subsequent extubation were
significantly less with SS
SS and ISO could both safely used in
OPCAB; awakening and extubation
time were significantly lower with SS.20 Isoflurane ISO
20 Sevoflurne
Lucchinetti et al. (2007)
Anesthesiology, Switzerland [37]
Prospective randomised trial
20 OPCAB SS Troponin, NBP and associate
pregnancy-associated plasma
protein A release Gene
expression profile
(atrial biopsies)
NPB and protein A were decrease in SS
group; Echo showed preserved post-op
LV function in SS group.
SS gene regulatory control of myocardial
substrate metabolism predicted
postoperative cardiac function in
OPCAB patients
10 Propofol PP
10 Sevoflurane
Guarracino et al. (2006) Journal of
Cardiothoracic and Vascular
Anesthesia, Italy [41] Prospective
randomised trial
One hundred
twelve
DES Troponin release Post-op peak troponin was significantly
lower in DES group
Myocardial damage measured by
cardiac troponin release could be
reduced by DES during OPCAB
OPCAB PP
57 Desflurane (in addition to
opiate-based
anesthesia)55 Propofol
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Table 2 Studies including anaesthetics agents (Continued)
Law-Koune (2006) J Cardiothorac
Vasc Anesth, France [30] Prospective
randomized trial
Eighteen OPCAB SS-REMI Troponin release No difference in troponin release Study did not support cardio-protective
effects of SS
9 Sevoflurane-
remifentanil
PP-REMI
9 Propofol-
remifentanil
Bein et al. (2005) Anesth Analg,
Germany [43] Prospective
randomized trial
Fifty-two OPCAB
(MIDCAB)
SS Myocardial function Myocardial performance index and
early to atrial filling velocity ratio in the
PP group deteriorated significantly
whereas there was no change in
the SS group
In patients undergoing MIDCAB surgery,
SS preserved myocardial function
better than PP
26 Sevoflurane PP
26 Propofol
Kendall (2004) Anaesthesia,
UK [39] Prospective
randomized trial
Thirty OPCAB PP Troponin release No significant difference in
between groups
No support of ISO as cardioprotective
agent was reported
10 Propofol ISO
10 Isoflurane ISO/high thoracic
epidural analgesia
10 Isoflurane and
high thoracic
epidural analgesia
Conzen et al. (2003)
Anesthesiology, Germany [27]
Prospective randomized trial
Twenty OPCAB SS Troponin release Troponin increased significantly more in
the PP group rather than in the SS group
Patients receiving SS had less myocardial
injury during the first 24 post-op hours
than patients with PP10 Sevoflurane
10 Propofol
AF: Atrial fibrillation; BNP: Brain natriuretic peptide ONCAB: On pump Coronary Artery By-pass Grafting; OPCAB: Off pump Coronary Artery By-pass Grafting; DES: Desflurane IP: Ischemic preconditioning; LAD: Left anterior
descending artery; LVWMS: Left ventricle wall motion score; MIDCAB: Minimally invasive direct coronary artery bypass grafting; PostC: Postconditioning; SS: Sevoflurane.
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lease. Li et al. [6] randomized a small number of patients
to on and off-pump to be preconditioned with the use of
hyperbaric oxygen (HBO). Patients in the precondition-
ing group underwent HBO for 70 min/daily for 5 con-
secutive days before surgery. Preconditioning with HBO
resulted in both cerebral and cardiac protective effects
as determined by biochemical markers of neuronal and
myocardial injury and clinical outcomes in patients
undergoing ONCAB while no benefits were observed in
the OPCAB group. Matsumoto et al. [24] reviewed a co-
hort of 48 OPCAB patients. Among them, the subgroup
treated with IP plus allopurinol and nicorandil had an
improved post-ischemic functional recovery after surgery.
Myocardial conditioning in cardiac surgery can be
achieved in different ways. The most used are central or
remote preconditioning and volatile anesthetics, while
adenosine or other pharmacological agents less fre-
quently used. Ischemic conditioning was first reported
in 1986 [4] and conditioning by volatile anesthetic with
halothane in 1976 [44]. Although different, both tech-
niques share probably some common mechanisms of ac-
tion and, most importantly, can be used simultaneously.
Both have been frequently utilized in ONCAB [45], but
with regard of OPCAB surgery no large trials have been
published so far evaluating their effect on troponin [19]
or clinical outcomes. Moreover, according to clinical
trial.gov [46], while there are different trials in different
phases, registered and ongoing, investigating the effect
of RIPC in ONCABG (isolated or plus/minus valve sur-
gery) the only trial aiming to compare the effect of RIPC
on ON and OFF-pump CABG is the RIP-CON study,
expected to report in June 2015 [47]. Small trials are
present in the literature, focusing on the effect of RIPC
on different subsystem outcomes. Joung et al. [16] ran-
domised 70 OPCAB patients to RIPC and control with
cognitive function as primary end points. Hong et al.
reported no differences in terms of troponin release in
OPCAB after RIPC [19]. Same Authors [18], however,
studied the effect of RIPC and PostC together and they
observed, this time, a reduction of troponin release in a
series of OPCAB. All the other trials [13,14,17,20-22,48]
carried out in OPCAB with conditioning used ‘central
preconditioning’, hence eliciting protection by cycles of
occlusion/reperfusion at the level of targeted vessel. All
of them led to different and non-homogeneous results.
Central remote ischemic preconditioning has been, how-
ever, fairly dismissed in on pump cardiac surgery and
during interventional cardiology procedure for its im-
practicality and its high level of invasiveness [2,3,49]. It
is important to stress that some of the RIPC and central
IP trials did not state the type of anesthesia used [13,23],
or deliberately used propofol as anesthetic maintenance
[12,16-18,20], while very few did not use it [19,21,22].Recently it has been reported that propofol may inhibit
preconditioning effect, and large trials have intentionally
avoided it use [50].
Since the first report in 1976 [44] volatile anaesthetics
have been frequently used as conditioning techniques in
ONCAB. Two large meta-analyses from 2006 [51,52]
have suggested that there was a significant difference in
in patients who received volatile agents in terms of re-
duced troponin release, improved CI, less use of inotropes
and reduced need of mechanical ventilation. However they
did not point out any differences with regards of mortality,
LOS and myocardial infarction rate. Moreover a relatively
recent review [53] has reported that sevoflurane had bene-
ficial effects only in naïve patients with no previous expo-
sures to episode of angina. Although there is sufficient
evidence to support the use of volatile agents during car-
diac surgery and taking into account their feasibility to be
used as pre, per and post conditioning with the potential
to prolong the protective effect [25], no large trials have
been set in place in order to identify potential benefits in
patients undergoing OPCAB. Up till now there are 17 tri-
als comparing different volatile anesthetics vs propofol or
vs control or volatiles among themself but the vast major-
ity of them were underpowered and led to conflictive
results (Table 2). Sevoflurane is proven to reduce troponin
level after on-pump surgery but its effect is still unclear in
the off-pump scenario. With regard to OPCAB, sevoflur-
ane was found to preserve cardiac function in three stud-
ies [35,37,54], to reduce troponin release in two studies
[26,27], to have antioxidant properties in one [33] and to
prevent incidence of arrhythmias in one [34]. On the
contrary sevoflurane did not show any better troponin
reduction when compared to other agents in four studies
[28-31]. Only Orriach et al. used sevoflurane during and
after the operation as post-conditioning and reported a
significant reduction in troponin release [25].
Conclusions
Although OPCAB is thought to reduce the extent of
general ischemia, ischemic cardiac insult can be found
in up to 10% of the patients [12]. Data coming from the
largest pooled analysis on mainly on-pump experience
reported a trend toward a consistent reduction of almost
a half of MI in RIPC groups [55]; hence there may be
the theoretical potential to translate the same advantage
to off-pump patients. However, up till now there are no
strong evidences supporting the use of ischemic precon-
ditioning, either central or remote, in OPCAB patients.
In terms of volatile anaesthetics, taking into account
all the trials, we can conclude here that has not yet been
demonstrated if they can reduce troponin level after
off-pump surgery. Other forms of conditioning used in
OPCAB such as adenosine/HBO/pharmacological have
been used and some times in association with IP, but led
Moscarelli et al. Journal of Cardiothoracic Surgery  (2015) 10:7 Page 9 of 10to different conclusions. Conditioning, either elicited by
ischemia/reperfusion or by volatile agents, may theoretically
be a valid method to increase cardiac protection in
off-pump surgery, but further trials are definitely needed.
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